• Schedule 13D/G History

K2 HealthVentures Equity Trust LLC - Significant Ownership

Signature - Title
K2 HealthVentures Equity Trust LLC - Anup Arora, Managing Member
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by K2 HealthVentures Equity Trust LLC.

Significant Ownership of K2 HealthVentures Equity Trust LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TCRX TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share 6.9% $4.97M 3.6M K2 HealthVentures Equity Trust LLC Dec 31, 2024

Schedules 13D/G Reported by K2 HealthVentures Equity Trust LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.